Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

NEWS

japan-stocks-lower-at-close-of-trade;-nikkei-225-down-0.10%

Japan stocks lower at close of trade; Nikkei 225 down 0.10%

Mar 16, 2026

Japan stocks lower at close of trade; Nikkei 225 down 0.10%

Read more
new-break-announces-frankfurt-stock-exchange-listing-under-the-symbol-o91

New Break Announces Frankfurt Stock Exchange Listing Under the Symbol O91

Mar 16, 2026

This is a paid press release. Contact the press release distributor directly with any inquiries. TMX Newsfile Mon,…

Read more
top-china-ai-gpu-stocks-to-watch,-according-to-morgan-stanley

Top China AI GPU Stocks to Watch, According to Morgan Stanley

Mar 16, 2026

Top China AI GPU Stocks to Watch, According to Morgan Stanley

Read more
the-stock-market-is-near-its-peak-dot-com-era-valuation-—-here’s-why-you-shouldn’t-worry

The Stock Market Is Near Its Peak Dot-Com Era Valuation — Here’s Why You Shouldn’t Worry

Mar 16, 2026

Investors and consumers alike are worried about a potential bear market and recession. Since the start of 2026,…

Read more
bitcoin-gains-13%-amid-iran-conflict-as-btc-price-decouples-from-broader-stock-and-gold-market

Bitcoin Gains 13% amid Iran Conflict as BTC Price Decouples from Broader Stock and Gold Market

Mar 16, 2026

Bitcoin (BTC-USD) is on track to close its strongest week since September 2025, rising about 8.5% and trading…

Read more
i’m-preparing-for-a-violent-stock-market-crash

I’m preparing for a violent stock market crash

Mar 16, 2026

Image source: Getty Images A stock market crash may be coming. Why? Valuations look elevated. The conflict in…

Read more
citi-cuts-india’s-nifty-target-to-27,000-on-earnings,-macro-risks-from-raging-iran-war

Citi cuts India’s Nifty target to 27,000 on earnings, macro risks from raging Iran war

Mar 16, 2026

Please enable JS and disable any ad blocker

Read more
akeso-shares-rise-as-cancer-drug-candidate-enters-clinical-trials

Akeso shares rise as cancer drug candidate enters clinical trials

Mar 16, 2026

Akeso shares rise as cancer drug candidate enters clinical trials

Read more
the-stock-market-is-near-its-peak-dot-com-era-valuation-—-here’s-why-you-shouldn’t-worry

The Stock Market Is Near Its Peak Dot-Com Era Valuation — Here’s Why You Shouldn’t Worry

Mar 16, 2026

Investors and consumers alike are worried about a potential bear market and recession. Since the start of 2026,…

Read more
australia-stocks-lower-at-close-of-trade;-s&p/asx-200-down-0.39%

Australia stocks lower at close of trade; S&P/ASX 200 down 0.39%

Mar 16, 2026

Australia stocks lower at close of trade; S&P/ASX 200 down 0.39%

Read more
goldman-sachs-sets-the-tone-for-the-us-stock-market:-earnings-expansion-supports-upside-potential,-with-the-s&p-500-index-expected-to-reach-7,600-points-by-the-end-of-this-year.

Goldman Sachs sets the tone for the U.S. stock market: earnings expansion supports upside potential, with the S&P 500 Index expected to reach 7,600 points by the end of this year.

Mar 16, 2026

The U.S. stock market still has room for upward movement, and driven by continued corporate earnings growth and…

Read more
asia-stocks-fall-as-iran-war,-oil-surge-weigh;-chinese-data-in-focus

Asia stocks fall as Iran war, oil surge weigh; Chinese data in focus

Mar 16, 2026

Asia stocks fall as Iran war, oil surge weigh; Chinese data in focus

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 316
  6. 317
  7. 318
  8. 319
  9. 320
  10. 321
  11. 322
  12. ...
  13. 3466
  14. »

Posts pagination

Newer posts Page 1 … Page 319 … Page 3,466 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.